
1. int j std aids. 2006 jul;17(7):436-41; quiz 442.

therapeutic immunization control hiv-1: now?

dorrell l(1).

author information: 
(1)mrc human immunology unit, weatherall institute molecular medicine, john
radcliffe hospital, oxford ox3 9ds, uk. ldorrell@gwmail.jr2.ox.ac.uk

highly active antiretroviral therapy (haart) transformed hiv-1 infection from
an invariably fatal disease chronic infection requiring lifelong
treatment. however, challenges still face urgent need provide
affordable sustainable therapy millions infected individuals live
in resource-poor countries, limitations posed serious drug toxicity
and viral resistance associated long-term therapy. augmentation of
hiv-specific immunity therapeutic vaccination possible alternative to
continuous haart. review, progress development therapeutic
immunization strategies discussed.

doi: 10.1258/095646206777689035 
pmid: 16820070  [indexed medline]

